Feed RDNT
RD

RadNet RDNT · NASDAQ

$69.27 +0.68% (+$0.47)

Market cap
$5.45B
Enterprise value
$6.91B
P/E
-
Forward P/E
140.0x
PEG
-
P/S
2.4x
P/FCF
-
EV/EBITDA
20.5x
ROIC
1.4%
Gross margin
9.7%
Net margin
-0.9%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
4.3x
Beta
1.41
Free float
89.5%

About the company

RadNet, Inc. (RDNT) is an American company specializing in providing diagnostic imaging services and outpatient healthcare. With an extensive network of radiology centers across the United States, RadNet is one of the leading providers of advanced diagnostic services for physicians and patients. The company focuses on providing a wide range of high-quality imaging examinations, including X-rays, magnetic resonance imaging (MRI), and computed tomography (CT), as well as innovative technologies that aid in timely and accurate disease diagnosis. RadNet, Inc. (RDNT) could be suitable for investors seeking opportunities in the healthcare sector with an emphasis on diagnostic services and advanced imaging technologies.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Howard G. Berger

Employees

9,060

Headquarters

Los Angeles

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.